Polycystic ovary syndrome (PCOS) is a very frequent endocrine disorder in women since it occurs in as many as 8–10% of women of reproductive age [1, 2]. Due to the multiple heterogeneity of the syndrome [3], there has been no agreement on the criteria on which to base the diagnosis of PCOS.
Polycystic Ovary Syndrome: Considerations About Therapeutic Strategies Choices from Fertile Life to Menopause / Genazzani, A. D.; Fedora, A.; Giulia, D.; Alba, M.; Martina, C.; Melania, A.; Tabatha, P.; Veronica, T.; Genazzani, A. R.. - (2021), pp. 67-74. [10.1007/978-3-030-63650-0_6]
Polycystic Ovary Syndrome: Considerations About Therapeutic Strategies Choices from Fertile Life to Menopause
Genazzani A. D.;Martina C.;
2021
Abstract
Polycystic ovary syndrome (PCOS) is a very frequent endocrine disorder in women since it occurs in as many as 8–10% of women of reproductive age [1, 2]. Due to the multiple heterogeneity of the syndrome [3], there has been no agreement on the criteria on which to base the diagnosis of PCOS.Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris